Ask Dr. NeelumA column on memory, the aging brain and Alzheimer's researchChicago · Reviewed
Q.

Is this ordinary forgetfulness, or something worth getting checked?

A.It is the question I hear most, from patients and from the families sitting beside them. This site answers it, and the questions that follow, in plain language and with the evidence shown.

Q.

Who is answering?

Memory changes deserve a real evaluation: not a shrug, and not a panic.

Dr. Neelum Aggarwal is a board-certified cognitive neurologist, clinical trialist and Professor in the Department of Neurological Sciences at Rush University Medical Center in Chicago.

She is senior examining neurologist for the Rush Alzheimer's Disease Center's Clinical Core, where she diagnoses and cares for people with memory changes, mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. She is also research director of the Rush Heart Center for Women and works with its Cardiology Cognitive Clinic, which brings heart and brain care together.

Her research looks at why some people are at higher risk of cognitive decline: heart and blood-vessel health, social circumstances, and differences between women and men. She has helped lead national Alzheimer's prevention and treatment trials at Rush.

Read Dr. Aggarwal's background
Q.

How common is this, really?

The numbers behind the questions. Each comes from a published source, listed below.

7.4m

Americans aged 65 and older living with Alzheimer's disease in 2026

Alzheimer's Association, 2026 Facts and Figures
⅔

of Americans with Alzheimer's are women — almost two in every three

Alzheimer's Association, 2026 Facts and Figures
1 in 5

estimated lifetime risk of Alzheimer's for a woman at age 45 (1 in 10 for a man)

Alzheimer's Association, 2026 Facts and Figures
13m

Nearly that many Americans give unpaid care to someone living with dementia

Alzheimer's Association, 2026 Facts and Figures
45%

of dementia cases worldwide potentially linked to 14 modifiable risk factors

Lancet Commission, 2024

Sources: Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures; Livingston et al., Lancet 2024. The 45% figure is a worldwide population estimate, not an individual's risk.

Q.

What do people get wrong about memory loss?

Six beliefs that keep families from getting help, and what the evidence says instead.

What people often thinkMemory loss is just part of getting old.
What the evidence says

Some slowing is normal with age. Memory loss that disrupts daily life is not, and it deserves an evaluation.

What people often thinkMy parent had Alzheimer's, so I will too.
What the evidence says

Family history raises risk, but it is not destiny. Genes that directly cause Alzheimer's are rare, and many people with an affected parent never develop it.

What people often thinkIf nothing can be done, why get checked?
What the evidence says

Some causes of memory trouble are treatable. An early, accurate diagnosis also opens doors to treatment choices, planning and research.

What people often thinkMild cognitive impairment always turns into dementia.
What the evidence says

Many people with MCI stay stable for years, and some return to normal thinking. The cause makes a big difference.

What people often thinkA memory supplement will protect my brain.
What the evidence says

Supplements are not reviewed by the FDA for effectiveness. The strongest evidence points to heart health, hearing care, activity and social connection.

What people often thinkClinical trials are a last resort.
What the evidence says

Many studies seek healthy volunteers or people with early memory concerns. Taking part is voluntary, and you can leave at any time.

Q.

Normal aging, MCI or dementia — what's the difference?

A simplified guide. Only a full evaluation can tell which applies to a particular person.

Comparison of normal aging, mild cognitive impairment and dementia
Typical agingMild cognitive impairmentDementia
MemoryOccasionally forgets a name or appointment, remembers laterForgets more than expected for age; noticeable on testingMemory loss that disrupts daily life; new information is quickly lost
Daily lifeFully independentMostly independent; complex tasks may take more effortNeeds help with tasks such as bills, medicines, cooking or driving
Who noticesUsually the person themselvesThe person and often close familyFamily and friends; the person may not be aware
Over timeStableMay stay stable, improve, or progressUsually progresses; the pace varies by cause
Next stepHealthy habits; mention concerns at check-upsEvaluation to find the cause; follow-up every 6–12 monthsDiagnosis, treatment options, safety and support planning

Based on information from the Alzheimer's Association on warning signs and mild cognitive impairment.

Q.

What should I bring to a first memory visit?

  • A list of every medicine and supplement, with doses
  • A few specific examples of what has changed, and roughly when it started
  • A family member or close friend who knows you well
  • Recent test results, brain scans and notes from other doctors
  • Your hearing aids and glasses, if you use them
  • Your questions, written down
Q.

Quick answers

Requirements depend on your insurance plan. Check with your insurer, and ask the office when you get in touch.

Yes, and it helps. Someone who knows you well can describe changes you may not notice yourself.

A first visit is usually longer than a routine appointment because it includes a detailed history and thinking tests. Further testing, such as imaging or neuropsychological testing, may be scheduled separately.

Not yet. Some medicines can ease symptoms for a time, and two newer medicines can modestly slow early Alzheimer's in carefully selected patients. Good care, support and planning help at every stage.
All frequently asked questions
Q.

Why does a neurologist run clinical trials?

Because every test and treatment patients rely on today was proven, or disproven, by volunteers in research.

Dr. Aggarwal has served as a site principal investigator and steering committee member for NIH-funded Alzheimer's trials. She has also worked to make it easier for women and people from diverse communities to take part.

How research participation works
  1. Learn what a study involves

    Purpose, visits, risks, and whether a placebo is used.

  2. Talk it over

    With family, your own doctor and the study team.

  3. Give informed consent

    Only if you choose to. You can leave at any time.

  4. Take part, with support

    Regular visits and monitoring for your safety.

Q.

What else are readers asking?

Recent answers from the column.

All articles
Q.

Why trust what you read here?

Read the editorial policy

Written by a specialist

Content is written for and approved by Dr. Aggarwal, a cognitive neurologist.

Sources you can check

Medical statements cite guidelines and studies, linked on every page.

Dated and reviewed

Each medical page shows when it was last reviewed, and is re-checked as treatments change.

No sponsors

No advertising, no paid placements, no products for sale.

Clear about limits

General education only. Pages say when to see a doctor or call 911.

Honest about uncertainty

Where experts disagree, as they do about the new Alzheimer's drugs, both sides are shown.

SpecialtyNeurology, cognitive neurology
Academic titleProfessor, Rush University
Clinical homeRush Alzheimer's Disease Center
Verify a licenseIllinois IDFPR (opens in a new tab)

Worried about memory changes in you or someone you love?

Email [email protected] and the office will reply with how to book a visit with Dr. Aggarwal at Rush University Medical Center.